Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy

Department of Cardiological Sciences, St. George's Hospital Medical School, London, England.

To determine whether organ-specific cardiac autoantibodies are present in dilated cardiomyopathy, indirect immunofluorescence on human heart and skeletal muscle was used to test sera from 200 normal subjects and from 65 patients with dilated cardiomyopathy, 41 with chronic heart failure due to myocardial infarction and 208 with other cardiac disease. Three immunofluorescence patterns were observed: diffuse cytoplasmic on cardiac tissue only (organ-specific), fine striational on cardiac and, to a lesser extent, skeletal muscle (cross-reactive 1) and broad striational on both cardiac and skeletal muscle (cross-reactive 2). Cardiac specificity of the cytoplasmic pattern was confirmed by absorption studies with homogenates of human atrium, skeletal muscle and rat liver. Organ-specific cardiac antibodies (IgG; titer range 1/10 to 1/80) were more frequent in patients with dilated cardiomyopathy (17 [26%] of 65) than in those with other cardiac disease (2 [1%] of 208, p less than 0.0001) or heart failure (0 [0%] of 41, p less than 0.001) or in normal subjects (7 [3.5%] of 200, p less than 0.0001). Organ-specific cardiac antibodies were more common in patients with dilated cardiomyopathy and in those with fewer symptoms (8 of 15 in New York Heart Association functional class I versus 9 of 50 in classes II to IV, p less than 0.01) and more recent (less than 2 years) onset of disease (9 of 19 versus 8 of 46, p less than 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Valaperti, R. R. Marty, G. Kania, D. Germano, N. Mauermann, S. Dirnhofer, B. Leimenstoll, P. Blyszczuk, C. Dong, C. Mueller, et al. CD11b+ Monocytes Abrogate Th17 CD4+ T Cell-Mediated Experimental Autoimmune Myocarditis J. Immunol., February 15, 2008; 180(4): 2686 - 2695. [Abstract] [Full Text] [PDF]

				A. L.P. Caforio, F. Calabrese, A. Angelini, F. Tona, A. Vinci, S. Bottaro, A. Ramondo, E. Carturan, S. Iliceto, G. Thiene, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis Eur. Heart J., June 1, 2007; 28(11): 1326 - 1333. [Abstract] [Full Text] [PDF]

				A. L.P. Caforio, N. G. Mahon, M. K. Baig, F. Tona, R. T. Murphy, P. M. Elliott, and W. J. McKenna Prospective Familial Assessment in Dilated Cardiomyopathy: Cardiac Autoantibodies Predict Disease Development in Asymptomatic Relatives Circulation, January 2, 2007; 115(1): 76 - 83. [Abstract] [Full Text] [PDF]

				M. Rangachari, N. Mauermann, R. R. Marty, S. Dirnhofer, M. O. Kurrer, V. Komnenovic, J. M. Penninger, and U. Eriksson T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17 J. Exp. Med., August 7, 2006; 203(8): 2009 - 2019. [Abstract] [Full Text] [PDF]

				A L. Caforio, L Daliento, A Angelini, S Bottaro, A Vinci, G Dequal, F Tona, S Iliceto, G Thiene, and W J McKenna Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies Lupus, September 1, 2005; 14(9): 652 - 655. [Abstract] [PDF]

				M G. Gagliardi, M Bevilacqua, C Bassano, B Leonardi, R Boldrini, F D. Camassei, A Fierabracci, A G Ugazio, and G F Bottazzo Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy Heart, October 1, 2004; 90(10): 1167 - 1171. [Abstract] [Full Text] [PDF]

				J. W Mason Myocarditis and dilated cardiomyopathy: An inflammatory link Cardiovasc Res, October 15, 2003; 60(1): 5 - 10. [Abstract] [Full Text] [PDF]

				A. Frustaci, C. Chimenti, F. Calabrese, M. Pieroni, G. Thiene, and A. Maseri Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders Circulation, February 18, 2003; 107(6): 857 - 863. [Abstract] [Full Text] [PDF]

				P. Liu, P. Lee, K. Fuse, and M. Nian Molecular pathophysiological mechanisms in virus infected host myocardium Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I37 - I41. [Abstract] [PDF]

				A. L.P. Caforio, N. J. Mahon, F. Tona, and W. J. McKenna Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance Eur J Heart Fail, August 1, 2002; 4(4): 411 - 417. [Abstract] [Full Text] [PDF]

				R. Wojnicz, E. Nowalany-Kozielska, C. Wojciechowska, G. Glanowska, P. Wilczewski, T. Niklewski, M. Zembala, L. Polonski, M. M. Rozek, and J. Wodniecki Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy : Two-Year Follow-Up Results Circulation, July 3, 2001; 104(1): 39 - 45. [Abstract] [Full Text] [PDF]

				A. L.P. Caforio, J. H. Goldman, M. K. Baig, N. J. Mahon, A. J. Haven, B. E. Souberbielle, D. W. Holt, A. G. Dalgleish, and W. J. McKenna Elevated serum levels of soluble interleukin-2 receptor, neopterin and {beta}-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis Eur J Heart Fail, March 1, 2001; 3(2): 155 - 163. [Abstract] [Full Text] [PDF]

				P F Currie, J H Goldman, A L P Caforio, A J Jacob, M K Baig, R P Brettle, A J Haven, N A Boon, and W J McKenna Cardiac autoimmunity in HIV related heart muscle disease Heart, June 1, 1998; 79(6): 599 - 604. [Abstract] [Full Text]

				J. Muller, G. Wallukat, Y.-G. Weng, M. Dandel, S. Spiegelsberger, S. Semrau, K. Brandes, V. Theodoridis, M. Loebe, R. Meyer, et al. Weaning From Mechanical Cardiac Support in Patients With Idiopathic Dilated Cardiomyopathy Circulation, July 15, 1997; 96(2): 542 - 549. [Abstract] [Full Text]